Search Grant Opportunities

Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional)

ID: RFA-FD-19-006 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)

Description

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for UG3/UH3 cooperative agreements to support the development of a publicly available core set(s) of COAs and their related endpoints for specific disease indications.

The UG3/UH3 Phase Innovation Award Cooperative Agreement involves 2 phases. The UG3 phase will provide funding for 1 to 2 years to conduct planning activities. The UH3 phase will provide funding for 3 to 4 years to projects that successfully complete the planning activities and reach the projected milestones set in the UG3 phase. UH3 phase awards will be awarded after administrative review of eligible UG3 phase awards that have met the scientific milestone and feasibility requirements necessary for UH3 phase implementation. The number of awards is dependent on the availability of funds. The UG3/UH3 application must be submitted as a single application, and applicants should note specific instructions for each phase in this FOA. The total award project period will not exceed 5 years.

Show All

Overview

Agency
Food and Drug Administration (FDA) [HHS]
Category of Funding
Food and Nutrition
Health
Science and Technology and other Research and Development
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
93.103 - Food and Drug Administration Research
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 2/20/19 Food and Drug Administration posted grant opportunity RFA-FD-19-006 for Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional) with funding of $4.2 million. The grant will be issued under grant program 93.103 Food and Drug Administration Research. It is expected that 3 total grants will be made.

Timing

Posted Date
Feb. 20, 2019, 12:00 a.m. EST
Closing Date
May 31, 2019, 12:00 a.m. EDT Past Due
Last Updated
Feb. 20, 2019, 10:13 a.m. EST
Version
1
Archive Date
June 30, 2019

Eligibility

Eligible Applicants
County governments
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Private institutions of higher education
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Public and State controlled institutions of higher education
State governments
Special district governments
Native American tribal governments (Federally recognized)
Small businesses
Additional Info
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Award Sizing

Ceiling
$1,400,000
Floor
Not Listed
Estimated Program Funding
$4,200,000
Estimated Number of Grants
3

Contacts

Contact
Lisa Ko Grants Management Officer
Contact Email
shashi.malhotra@fda.hhs.gov   Profile
Contact Phone
(301) 796-8020
Additional Information
Full Announcement of RFA-FDA-19-006 on NIH Guide for Grants and Contracts
Additional Information Site
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-006.html

Documents

Posted documents for RFA-FD-19-006

Grant Awards

Grants awarded through RFA-FD-19-006

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-FD-19-006

Experts for Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional)

Recommended subject matter experts available for hire